Cargando…

Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutter

INTRODUCTION: Identifying the critical isthmus region (CIR) of atrial re‐entry tachycardias (AT) is challenging. The Lumipoint® (LP) software, developed for the Rhythmia® mapping system, aims to facilitate the successful ablation of ATs by identifying the CIR. OBJECTIVE: The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vonderlin, Nadine, Siebermair, Johannes, Mahabadi, Amir, Pesch, Elena, Koehler, Miriam, Dobrev, Dobromir, Janosi, Rolf Alexander, Rassaf, Tienush, Wakili, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Clinical Trial Result
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189070/ https://www.ncbi.nlm.nih.gov/pubmed/36971117 http://dx.doi.org/10.1002/clc.24009

Ejemplares similares

Role of catheter location on local impedance measurements and clinical outcome with the new direct sense technology in cardiac ablation procedures
por: Pesch, E., et al.
Publicado: (2022)

Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator
por: Kaya, Elif, et al.
Publicado: (2019)

Impact of diabetes as a risk factor in patients undergoing subcutaneous implantable cardioverter defibrillator implantation: A single-centre study
por: Kaya, Elif, et al.
Publicado: (2020)

Central retinal artery occlusion as a first sign of atrial fibrillation: A 3‐year retrospective single‐center analysis
por: Vonderlin, Nadine, et al.
Publicado: (2021)

Atypical Flutter with Atrial Isochronal Late-activation Map Correlating with the Critical Isthmus
por: Kapur, Sunil
Publicado: (2021)

Omnipolar mapping improves substrate characterization and critical isthmus identification in atypical atrial flutters
por: China, P, et al.
Publicado: (2023)

Early Pacemaker Implantation after Transcatheter Aortic Valve Replacement: Impact of PlasmaBlade™ for Prevention of Device-Associated Bleeding Complications
por: Lind, Alexander, et al.
Publicado: (2021)

Atrial flutter with an epicardial and endocardial breakthrough in the cavotricuspid isthmus
por: Kobayashi, Shuhei, et al.
Publicado: (2021)

Intracardiac Echocardiography Guidance Improves Procedural Outcomes in Patients Undergoing Cavotricuspidal Isthmus Ablation for Typical Atrial Flutter
por: Turcsan, Marton, et al.
Publicado: (2023)

Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19
por: Wesemann, Ulrich, et al.
Publicado: (2021)

An Approach to Catheter Ablation of Cavotricuspid Isthmus Dependent Atrial Flutter
por: O’Neill, Mark D, et al.
Publicado: (2006)

Cavotricuspid isthmus ablation for atrial flutter: Anatomic challenges and troubleshooting
por: Christopoulos, Georgios, et al.
Publicado: (2020)

Gap-related Pulmonary Vein and Left Atrial Flutter Mimicking Cavotricuspid Isthmus-dependent Atrial Flutter
por: Komaki, Tomo, et al.
Publicado: (2020)

Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
por: Kupusovic, Jana, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
por: Gao, Ming‐Yang, et al.
Publicado: (2023)

Safety and efficacy of ablation index‐guided atrial fibrillation ablation in octogenarians
por: Okamatsu, Hideharu, et al.
Publicado: (2023)

Self‐reported sleep pattern and recurrence of atrial fibrillation after catheter ablation
por: Cang, Jiehui, et al.
Publicado: (2023)

Ablation Of Atrial Flutter:Block (Isthmus Conduction) Or Not A Block, That Is The Question?
por: Nabar, Ashish
Publicado: (2002)

Transhepatic radiofrequency ablation of a cavotricuspid isthmus–dependent atrial flutter
por: Jehan Iqbal, Zahra, et al.
Publicado: (2016)

N‐terminal pro‐B‐type natriuretic peptide improves the predictive value of CHA(2)DS(2)‐VASc risk score for long‐term cardiovascular events in acute coronary syndrome patients with atrial fibrillation
por: Mu, Xuefei, et al.
Publicado: (2023)

Global longitudinal strain is associated with better outcomes in transcatheter aortic valve replacement
por: Al-Rashid, Fadi, et al.
Publicado: (2020)

Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients
por: Brembilla-Perrot, Béatrice, et al.
Publicado: (2015)

Access site complications following Impella-supported high-risk percutaneous coronary interventions
por: Johannsen, Laura, et al.
Publicado: (2019)

A Retrospective Study of Atrial Fibrillation Following Cavotricuspid Isthmus Ablation for Atrial Flutter
por: Warchoł, Izabela, et al.
Publicado: (2019)

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
por: Agarwal, Neeraj, et al.
Publicado: (2016)

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study
por: Chen, San-Chi, et al.
Publicado: (2016)

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
por: Bendell, Johanna C., et al.
Publicado: (2016)

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
por: Piperno-Neumann, Sophie, et al.
Publicado: (2016)

Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
por: Olszanski, Anthony J., et al.
Publicado: (2016)

A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer
por: Liu, Jian, et al.
Publicado: (2016)

A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
por: Lin, Jianqing, et al.
Publicado: (2016)

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
por: Chiappori, Alberto A., et al.
Publicado: (2016)

Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2016)

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy
por: Machiels, Jean-Pascal, et al.
Publicado: (2016)

A Phase I Dose‐Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low‐Grade or Intermediate‐Grade B‐Cell or T‐Cell Lymphoma
por: Foss, Francine Marie, et al.
Publicado: (2018)

Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned
por: de Brabander, Justin, et al.
Publicado: (2018)

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
por: Edelman, Gerald, et al.
Publicado: (2018)

A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
por: Ko, Andrew H., et al.
Publicado: (2017)

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results
por: O'Reilly, Eileen M., et al.
Publicado: (2017)

Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer
por: Araujo‐Mino, Emilio P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vcnavp6ahs48kg2ogmo68619lb